Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design

Nassir F. Marrouche, Tom Greene, J. Michael Dean, Eugene Kholmovski, Leonie Morrison‐de Boer, Moussa Mansour, Hugh Calkins, Francis E. Marchlinski, David J. Wilber, Gerhard Hindricks,

Journal of Cardiovascular Electrophysiology · 2021 · 84 citations · 30 references

Abstract

The DECAAF II trial is the first prospective, randomized, multicenter trial of patients with persistent AF using imaging defined atrial fibrosis as a treatment target. The trial will help define an optimal approach to catheter ablation of persistent AF, further our understanding of influencers of ablation lesion formation, and refine selection criteria for ablation based on atrial myopathy burden.

References

30